Loading...

Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

Cabinet approves setting up of India's first medical park

Image

05-Oct-16 Giving a push to local production of high-end medical equipment, the Indian government has given its nod to sub-lease over 300 acres of land in Chennai for the country's first medical devices manufacturing park. The project will reduce the dependence on imports and create a strong base for domestic industry by providing access to state-of-the-art infrastructure. [image: PTI]

Read More

Intuitive Surgical teams with Chinese company on lung cancer

Image

03-Oct-16 Intuitive Surgical is expanding into robotic-assisted catheter-based medical devices through a JV with Shanghai Fosun Pharmaceutical. These devices will use IP from Intuitive Surgical and will focus on diagnosis and treatment of lung cancer. R&D and manufacturing will take place in Shanghai. Intuitive Surgical will oversee distribution outside China while the JV will be in charge within China. [image: Asian Scientist Magazine]

Read More

Turkey’s medical tourism sector can be hair-raising

Image

02-Oct-16 746,000 foreign visitors landed in Turkey for medical treatment in 2015. As many as 100,000 arrived for hair implant surgeries, two-thirds of them from the UAE. Turkey earned US$5.8 bn from legal medical tourism in 2015. Medical treatment in Turkey can cost as little as half the price in countries such as Germany and the United States. [image: Murad / Reuters]

Read More

Singapore medical group expanding in China

Image

02-Oct-16 A pioneering Singapore fertility expert will head efforts to help Chinese women who find it hard to conceive, by setting up medical centres in China. They set up their first in Xiamen two years ago, and will open a centre in Chengdu by Dec-15. "We hope to expand into a network of 600 satellite women's clinics," said CEO Ms Bi. [image: Chew Seng Kim / ST]

Read More

80% of data in Chinese clinical trials fabricated

Image

01-Oct-16 A Chinese government investigation has revealed that more than 80% of the data used in clinical trials of new drugs have been "fabricated". The investigation, led by the SFDA, looked at data from 1,622 clinical trials. The SFDA found that the suspect data failed to meet analysis requirements, were incomplete, or totally non-existent. [image: Plavevski / Shutterstock / Science Alert]

Read More
Share

 


0111 Banner square pre launch 250x250